Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Acceleron Pharma Inc (XLRN)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Acceleron Pharma Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1280600.
Total stock buying since 2014: $100,246,002.
Total stock sales since 2014: $198,091,133.
Total stock option exercises since 2014: $24,620,985.
Table 3. Detailed insider trading at Acceleron Pharma Inc (XLRN) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2016-09-12 | Quisel John D (SVP, Bus. Dev., GC & Secretary) | Option Ex | 16,438 | 5.43 | 89,209 |
| 2016-08-10 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 18,896 | 6.20 | 117,155 |
| 2016-07-07 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 4,421 | 5.28 | 23,342 |
| 2016-07-07 | Knopf John L (CEO and President) | Option Ex | 95,000 | 1.80 | 171,000 |
| 2016-07-07 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 6,000 | 5.28 | 31,680 |
| 2016-07-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 5,000 | 3.88 | 19,400 |
| 2016-07-06 | Knopf John L (CEO and President) | Sale | 41,477 | 33.92 | 1,406,899 |
| 2016-07-06 | Knopf John L (CEO and President) | Option Ex | 41,477 | 5.28 | 218,998 |
| 2016-07-05 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 3,966 | 33.51 | 132,900 |
| 2016-07-05 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 3,966 | 5.28 | 20,940 |
| 2016-07-05 | Knopf John L (CEO and President) | Sale | 30,501 | 33.70 | 1,027,883 |
| 2016-07-05 | Knopf John L (CEO and President) | Option Ex | 30,501 | 5.28 | 161,045 |
| 2016-07-01 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 28,304 | 34.77 | 984,130 |
| 2016-07-01 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 28,304 | 4.58 | 129,632 |
| 2016-07-01 | Knopf John L (CEO and President) | Sale | 28,022 | 34.55 | 968,160 |
| 2016-07-01 | Knopf John L (CEO and President) | Option Ex | 23,022 | 5.28 | 121,556 |
| 2016-07-01 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 26,000 | 34.55 | 898,170 |
| 2016-07-01 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 14,000 | 4.75 | 66,458 |
| 2016-07-01 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 25,300 | 34.66 | 876,897 |
| 2016-07-01 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 15,300 | 5.28 | 80,784 |
| 2016-05-23 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 25,300 | 34.00 | 860,200 |
| 2016-05-23 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 300 | 5.28 | 1,584 |
| 2016-05-20 | Knopf John L (CEO and President) | Sale | 25,787 | 33.17 | 855,354 |
| 2016-05-20 | Knopf John L (CEO and President) | Option Ex | 25,787 | 5.08 | 130,997 |
| 2016-05-19 | Knopf John L (CEO and President) | Sale | 37,623 | 33.04 | 1,243,063 |
| 2016-05-19 | Knopf John L (CEO and President) | Option Ex | 37,623 | 5.08 | 191,124 |
| 2016-05-18 | Knopf John L (CEO and President) | Sale | 36,590 | 33.04 | 1,208,933 |
| 2016-05-18 | Knopf John L (CEO and President) | Option Ex | 24,090 | 5.08 | 122,377 |
| 2016-04-07 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 32,270 | 32.00 | 1,032,640 |
| 2016-04-07 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 32,270 | 5.34 | 172,321 |
| 2016-04-07 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 23,920 | 32.00 | 765,440 |
| 2016-04-07 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 14,000 | 5.08 | 71,120 |
| 2016-04-06 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 2,080 | 32.00 | 66,560 |
| 2016-01-11 | Celgene Corp /de/ (10% Owner) | Buy | 800,000 | 40.00 | 32,000,000 |
| 2015-12-22 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 7,500 | 3.88 | 29,100 |
| 2015-10-19 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 14,066 | 4.05 | 57,009 |
| 2015-10-15 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 6,000 | 23.30 | 139,830 |
| 2015-10-07 | Knopf John L (CEO and President) | Sale | 19,000 | 24.30 | 461,605 |
| 2015-10-07 | Knopf John L (CEO and President) | Option Ex | 19,000 | 5.08 | 96,520 |
| 2015-10-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 7,000 | 24.38 | 170,660 |
| 2015-10-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 7,000 | 3.88 | 27,160 |
| 2015-09-16 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 2,000 | 33.91 | 67,830 |
| 2015-09-15 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 33,000 | 35.00 | 1,155,000 |
| 2015-09-15 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 11,485 | 3.88 | 44,561 |
| 2015-09-15 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 2,000 | 33.61 | 67,220 |
| 2015-09-15 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 2,000 | 5.28 | 10,560 |
| 2015-09-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,500 | 33.62 | 184,910 |
| 2015-09-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,500 | 3.88 | 21,340 |
| 2015-09-14 | Knopf John L (CEO and President) | Option Ex | 8,500 | .40 | 3,400 |
| 2015-09-08 | Knopf John L (CEO and President) | Sale | 19,000 | 30.16 | 573,097 |
| 2015-09-08 | Knopf John L (CEO and President) | Option Ex | 19,000 | 5.08 | 96,520 |
| 2015-09-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 6,500 | 30.23 | 196,514 |
| 2015-09-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 6,500 | 3.88 | 25,220 |
| 2015-08-24 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 20,000 | 3.88 | 77,600 |
| 2015-08-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 7,000 | 31.39 | 219,751 |
| 2015-08-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-08-17 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 2,000 | 30.46 | 60,920 |
| 2015-08-17 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 2,000 | 5.28 | 10,560 |
| 2015-08-17 | Mcguire Terrance (Director) | Sale | 407,259 | 30.25 | 12,319,584 |
| 2015-08-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,500 | 30.98 | 170,390 |
| 2015-08-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,500 | 4.88 | 26,840 |
| 2015-08-10 | Knopf John L (CEO and President) | Sale | 19,000 | 28.86 | 548,435 |
| 2015-08-10 | Knopf John L (CEO and President) | Option Ex | 19,000 | 5.08 | 96,520 |
| 2015-08-10 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 6,500 | 28.76 | 186,940 |
| 2015-08-10 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 6,500 | 3.88 | 25,220 |
| 2015-07-30 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 13,422 | 5.28 | 70,868 |
| 2015-07-30 | Knopf John L (CEO and President) | Option Ex | 4,000 | .40 | 1,600 |
| 2015-07-28 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 5,000 | 3.88 | 19,400 |
| 2015-07-20 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 6,000 | 32.76 | 196,536 |
| 2015-07-20 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 4,800 | 2.78 | 13,343 |
| 2015-07-15 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 2,000 | 31.38 | 62,760 |
| 2015-07-15 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 2,000 | 4.58 | 9,160 |
| 2015-07-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,500 | 30.00 | 165,000 |
| 2015-07-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,500 | 5.88 | 32,340 |
| 2015-07-07 | Knopf John L (CEO and President) | Sale | 19,000 | 29.95 | 569,145 |
| 2015-07-07 | Knopf John L (CEO and President) | Option Ex | 19,000 | 4.48 | 85,120 |
| 2015-07-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 7,000 | 30.00 | 209,986 |
| 2015-07-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 7,000 | 3.88 | 27,160 |
| 2015-06-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 7,000 | 31.40 | 219,821 |
| 2015-06-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-06-17 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 7,701 | 3.88 | 29,879 |
| 2015-06-15 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,500 | 31.13 | 171,215 |
| 2015-06-15 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,500 | 5.88 | 32,340 |
| 2015-06-15 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 2,000 | 31.11 | 62,220 |
| 2015-06-15 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 2,000 | 3.88 | 7,760 |
| 2015-06-10 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 5,000 | 3.88 | 19,400 |
| 2015-06-08 | Knopf John L (CEO and President) | Sale | 19,000 | 32.72 | 621,680 |
| 2015-06-08 | Knopf John L (CEO and President) | Option Ex | 19,000 | 3.88 | 73,720 |
| 2015-06-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 6,500 | 32.70 | 212,537 |
| 2015-06-08 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 6,500 | 3.88 | 25,220 |
| 2015-05-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 7,000 | 32.30 | 226,135 |
| 2015-05-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-05-15 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 2,000 | 31.45 | 62,910 |
| 2015-05-15 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 2,000 | 3.88 | 7,760 |
| 2015-05-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,500 | 31.43 | 172,892 |
| 2015-05-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,500 | 5.88 | 32,340 |
| 2015-05-11 | Knopf John L (CEO and President) | Sale | 20,000 | 32.05 | 641,100 |
| 2015-05-11 | Knopf John L (CEO and President) | Option Ex | 25,000 | 2.84 | 71,000 |
| 2015-05-11 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 6,500 | 31.99 | 207,935 |
| 2015-05-11 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 11,500 | 3.88 | 44,620 |
| 2015-05-08 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 5,000 | 3.88 | 19,400 |
| 2015-04-20 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 5,000 | 33.52 | 167,575 |
| 2015-04-20 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 4,000 | .48 | 1,920 |
| 2015-04-16 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 12,000 | 3.88 | 46,560 |
| 2015-04-15 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 2,000 | 33.58 | 67,160 |
| 2015-04-15 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 2,000 | 3.88 | 7,760 |
| 2015-04-07 | Knopf John L (CEO and President) | Sale | 20,000 | 35.10 | 702,060 |
| 2015-04-07 | Knopf John L (CEO and President) | Option Ex | 5,000 | 3.88 | 19,400 |
| 2015-04-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 7,000 | 35.16 | 246,119 |
| 2015-04-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 7,000 | 3.88 | 27,160 |
| 2015-03-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 6,000 | 41.31 | 247,848 |
| 2015-03-18 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 4,800 | 2.78 | 13,343 |
| 2015-03-16 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 5,500 | 40.94 | 225,142 |
| 2015-03-16 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 5,500 | 5.88 | 32,340 |
| 2015-03-13 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 4,000 | 41.66 | 166,660 |
| 2015-03-13 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 4,000 | 5.08 | 20,320 |
| 2015-03-09 | Knopf John L (CEO and President) | Sale | 20,000 | 40.54 | 810,800 |
| 2015-03-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 6,500 | 40.54 | 263,529 |
| 2015-03-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 6,500 | 3.88 | 25,220 |
| 2015-03-04 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 5,500 | 41.27 | 226,957 |
| 2015-03-04 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 4,000 | 5.88 | 23,520 |
| 2015-03-04 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 9,500 | 41.40 | 393,281 |
| 2015-03-04 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 9,500 | 4.25 | 40,403 |
| 2015-03-04 | Ertel Steven D (EVP & Chief Operating Officer) | Sale | 5,000 | 41.29 | 206,450 |
| 2015-03-04 | Ertel Steven D (EVP & Chief Operating Officer) | Option Ex | 5,000 | 3.44 | 17,200 |
| 2015-03-04 | Sherman Matthew L (EVP & Chief Medical Officer) | Sale | 7,000 | 41.04 | 287,273 |
| 2015-03-04 | Sherman Matthew L (EVP & Chief Medical Officer) | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-02-09 | Knopf John L (CEO and President) | Sale | 20,000 | 36.90 | 737,900 |
| 2015-02-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 6,500 | 36.79 | 239,115 |
| 2015-02-09 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 6,500 | 3.88 | 25,220 |
| 2015-02-02 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 5,500 | 38.88 | 213,867 |
| 2015-02-02 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 4,000 | 5.88 | 23,520 |
| 2015-02-02 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 5,000 | 39.10 | 195,515 |
| 2015-02-02 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 5,000 | 1.80 | 9,000 |
| 2015-01-21 | Knopf John L (CEO and President) | Option Ex | 12,500 | .40 | 5,000 |
| 2015-01-20 | Sherman Matthew L (SVP & Chief Medical Officer) | Sale | 7,000 | 41.62 | 291,368 |
| 2015-01-20 | Sherman Matthew L (SVP & Chief Medical Officer) | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-01-15 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 2,000 | 40.79 | 81,580 |
| 2015-01-15 | Ertel Steven D (SVP & Chief Business Officer) | Option Ex | 2,000 | 3.88 | 7,760 |
| 2015-01-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Sale | 9,500 | 40.20 | 381,871 |
| 2015-01-14 | Quisel John D (SVP Gen. Counsel & Secretary) | Option Ex | 9,500 | 3.79 | 36,024 |
| 2015-01-12 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 1,500 | 40.58 | 60,862 |
| 2015-01-12 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 2,000 | 40.71 | 81,420 |
| 2015-01-12 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 2,000 | 3.88 | 7,760 |
| 2015-01-07 | Knopf John L (CEO and President) | Sale | 20,000 | 39.30 | 785,900 |
| 2015-01-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Sale | 5,000 | 39.13 | 195,650 |
| 2015-01-07 | Mclaughlin Kevin F (SVP, CFO and Treasurer) | Option Ex | 5,000 | 3.88 | 19,400 |
| 2015-01-02 | Kumar Ravindra (VP & Chief Scientific Officer) | Sale | 4,000 | 38.87 | 155,460 |
| 2015-01-02 | Kumar Ravindra (VP & Chief Scientific Officer) | Option Ex | 4,000 | 5.88 | 23,520 |
| 2015-01-02 | Ertel Steven D (SVP & Chief Business Officer) | Sale | 5,000 | 38.84 | 194,200 |
Insider trading activities including stock purchases, stock sales, and option exercises
of XLRN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Acceleron Pharma Inc (symbol XLRN,
CIK number 1280600) see
the Securities and Exchange Commission (SEC) website.